Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
97
天
Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling
作者
Chenglang Jiang; Weiqi Shen; Xin Liu; Yuhang Hui; Boru Hou展开收起
作者单位
1. The Second Hospital & Clinical Medical School, Lanzhou University , Lanzhou , Gansu , China; 2. Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University , Lanzhou , Gansu , China; 3. Academician Workstation of the Second Hospital & Clinical Medical School, Lanzhou University , Lanzhou , Gansu , China展开收起
22
天
Disitamab vedotin combined with PD-1 inhibitors for postoperative adjuvant therapy in upper tract urothelial carcinoma: a retrospective exploratory case series
作者
Yongbao Wei; Huaishan Hong; Dewen Zhong; Ruochen Zhang; Zhixuan Guo; Huang Lin; Jun Lin; Tao Li; Jinfeng Wu; Jianhui Chen; Yi Zhang展开收起
作者单位
1. Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, China; 2. Department of Urology, Longyan First Affiliated Hospital of Fujian Medical University, China; 3. Department of Urology, Fujian Medical University Union Hospital, China; 4. Department of Urology, The Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, China展开收起
26
天
Rare disease clinical trials in Italy (2022–May 2026): current trends, future challenges, and the evolving role as reporting member state
作者
Eleonora De Paola; Fabrizio Galliccia; Raffaella Maione; Natalia Maria Verrelli; Diego Alejandro Dri展开收起
作者单位
1. Clinical Trials Office, Italian Medicines Agency (AIFA), Italy; 2. Department of Pharmacy, School of Specialisation in Hospital Pharmacy, University of Pisa, Italy展开收起
48
天
Hormophysa cuneiformis protects against methamphetamine-induced hepatotoxicity via antioxidant, anti-inflammatory, and autophagy-regulatory mechanisms: histological and biochemical studies
作者
Mayada Elhusseiny; Rabab S. El-Kelany; Rania A. El-Shenody; Mohamed S. El-Hashash; Mostafa E. Elshobary; Samar Sami Alkafaas展开收起
作者单位
1. Histology and Cell Biology Department, Faculty of Medicine, Tanta University, Egypt; 2. Forensic Medicine and Clinical Toxicology at the Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Tanta University, Egypt; 3. Botany and Microbiology Department, Faculty of Science, Tanta University, Egypt; 4. Aquaculture Research, AWI-Helmholtz Centre for Polar and Marine Research, Germany; 5. Molecular Cell Biology Unit, Division of Biochemistry, Department of Chemistry, Faculty of Science, Tanta University, Egypt展开收起
50
天
Anti-tumor activity of valproic acid in EBV-positive Burkitt lymphoma via PFN2-associated PI3K/AKT pathway repression
作者
Yongliang Zheng; Yuxiu Yang; Shouhua Zhang; Rui Liu; Zujie Lin; Yuanqiao He; Yaoling Luo; Aili He展开收起
作者单位
1. Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 2. Department of Hematology, The Affiliated Hospital of Jinggangshan University, China; 3. School of Pharmacy, Jiangxi Science and Technology Normal University, China; 4. Department of General Surgery, Jiangxi Provincial Children’s Hospital, The Affiliated Children’s Hospital of Nanchang Medical College, China; 5. Center of Laboratory Animal Science, Nanchang University, China; 6. Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, China; 7. Clinical Medicine Research Center, First Affiliated Hospital of Gannan Medical University, China; 8. National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, China; 9. Department of Tumor and Immunology, Precision Medical Institute, Xi’an Jiaotong University, China; 10. Xi’an Key Laboratory of Hematological Diseases, China展开收起
58
天
FAQ
Frontiers in Pharmacology审稿要多久?
截至2026-11-19,CrushSCI 收录了 Frontiers in Pharmacology 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 17 天(Bioresponsive gelatin-coated silk fibroin nanoparticles enhance roxadustat therapy in experimental pulmonary fibrosis,2026-06-28 收稿,2026-07-15 录用),最慢一篇用了 207 天;平均 79.7 天,中位数 64 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
